Loading...

Aspen signs off on GSK drug transaction

Mar 01 2017 16:33
needle


Company Data

ASPEN PHARMACARE HOLDINGS LIMITED [JSE:APN]

Last traded 273
Change -2
% Change -1
Cumulative volume 324100
Market cap 0

Last Updated: 01/01/0001 at 12:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen sinks to four-month low as volumes surge after Glaxo sells

Glaxo sells stake in SA's Aspen for R8.47bn

Aspen targets further Chinese acquisitions

Aspen continues spending spree with $372m purchase

Aspen heads for biggest decline in 17 years

Aspen expands in China as it targets global growth

 

Cape Town - South Africa's biggest generic drug maker Aspen Pharmacare [JSE:APN] signed off on an agreement with GlaxoSmithKline to acquire a portfolio of anaesthetics, the company reported on Wednesday.

The company will pay an initial amount of £180m, paying an added £100m if certain goals are met in the three years following completion, according to a statement issued on Wednesday.

READ: Aspen continues spending spree with $372m purchase

The transaction was completed on February 28 2017 on a global scale and on a national scale in Durban on March 1 2017. The deal adds to the anaesthetics Aspen bought in June from AstraZeneca of the UK for as much as $770m.

Aspen's shares declined 0.21% to R282.78 as of 16:32 on the Johannesburg Stock Exchange.

Read Fin24's top stories trending on Twitter:

Follow Fin24 on Twitter, Facebook, Google+ and Pinterest. 24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

aspen pharmacare  |  health  |  companies

NEXT ON FIN24X

 
 
 
 

Company Snapshot

We're Talking About...

Savings Month

It's never too late to start saving. Visit our special issue and add your voice.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Have you experience a sudden depletion in data before?

Previous results · Suggest a vote

Loading...